AYTU
$2.59
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.
Intraday
Recent News
Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Shift From Loss To Profit
With the business potentially at an important milestone, we thought we'd take a closer look at Aytu BioPharma, Inc.'s...
Aytu BioPharma Inc (AYTU) Q2 2026 Earnings Call Highlights: Navigating Challenges and ...
Aytu BioPharma Inc (AYTU) reports a mixed quarter with decreased revenues but a promising start for its novel depression treatment, EXXUA.
Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates
Aytu BioPharma (AYTU) delivered earnings and revenue surprises of -303.85% and +26.27%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for February 2nd
AAWH, AYTU and BCAL have been added to the Zacks Rank #5 (Strong Sell) List on February 2, 2026.
Positive Signs As Multiple Insiders Buy Aytu BioPharma Stock
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...